Monte Rosa Therapeutics, Inc.
GLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$73 | -$135 | -$109 | -$74 |
| Dep. & Amort. | $8 | $6 | $4 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $18 | $17 | $12 | $5 |
| Change in WC | $91 | $72 | -$2 | $6 |
| Other Non-Cash | -$3 | -$4 | $3 | $1 |
| Operating Cash Flow | $42 | -$44 | -$92 | -$59 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$19 | -$13 | -$10 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$230 | -$103 | -$384 | $0 |
| Inv. Sales/Matur. | $190 | $211 | $178 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$44 | $89 | -$219 | -$10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $27 | $20 | $238 |
| Stock Repurch. | -$1 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $99 | $0 | $0 | $140 |
| Financing Cash Flow | $99 | $27 | $20 | $378 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $96 | $72 | -$291 | $309 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $133 | $60 | $351 | $43 |
| End Cash | $229 | $133 | $60 | $351 |
| Free Cash Flow | $38 | -$63 | -$105 | -$69 |